Howe, Anita Y MCeccherini-Silberstein, FrancescaDietz, JuliaPopping, StephanieGrebely, JasonRodrigo, ChaturakaLennerstrand, JohanDouglas, Mark WParczewsk, MiloszHarrigan, P RichardPawlotsky, Jean-MichelGarcia, FedericoCollaborators, Shared2023-02-092023-02-092021-08-10http://hdl.handle.net/10668/18478The advent of direct-acting antivirals (DAAs) has transformed the treatment landscape of hepatitis C [...].enAttribution 4.0 Internationalhttp://creativecommons.org/licenses/by/4.0/Antiviral AgentsDrug Resistance, ViralGlobal HealthHepacivirusHepatitis CHumansIntersectoral Collaborationresearch article34452444open access10.3390/v130815801999-4915PMC8402898https://www.mdpi.com/1999-4915/13/8/1580/pdf?version=1628748030https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8402898/pdf